Common Stock, $0.01 par value
- Symbol
- MBOT
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Current Report · Items 7.01, 9.01 · 8-K
Microbot Medical Inc.
MBOTNASDAQEQUITYCurrent
Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On September 25, 2026, Microbot Medical Inc. (the “Company”) disseminated a press release updating certain growth strategies. The press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.…
Company context
Microbot Medical Inc. (NASDAQ: MBOT) is a pre-commercial stage medical technology company with a vision to improve the quality of care for millions of patients and providers globally. The Company has developed the world’s first single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. Further information about Microbot Medical® is available at http://www.microbotmedical.com.
Current securities
Recent company filings
- Regulation FD DisclosureOct 6, 2026
- Regulation FD DisclosureAug 11, 2026
- 10-Q filingAug 11, 2026
- Entry into a Material Definitive Agreement · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsAug 7, 2026
- Regulation FD DisclosureJul 21, 2026
Registered securities in this filing
MICROBOT MEDICAL INC. · 8-K · Filed 2026-09-28
Disclosure sections
Item 7.01Item 7.01 - Regulation FD Disclosure
Item
7.01 Regulation FD Disclosure.
On
September 25, 2026, Microbot Medical Inc. (the “Company”) disseminated a press release updating certain growth strategies.
The press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.
The
information in this Item 7.01, including the attached exhibit, is being furnished, and shall not be deemed to be filed for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities
of that section, nor shall it be incorporated by reference into any filings under the Securities Act of 1933, as amended, or the Exchange
Act, regardless of any incorporation by reference language of such filing. By furnishing the information in this Current Report on Form
8-K (“Form 8-K”) and the attached exhibit, the Company is making no admission as to the materiality of any information in
this Form 8-K or the exhibit.
Item
9.01. Financial Statements and Exhibits.
(d)
Exhibits
Exhibit Description
Number
──────────────────────────────────────────────────────────────────────────────────────
10.1 Press Release
104 Cover
Page Interactive Data File (embedded within the Inline XBRL document)